VCMCVC Market Cap
Menu

Olive valuation, funding and investors

Olive works in healthcare revenue cycle automation solutions, based in United States. Founded in 2012, it has about 660 employees.

Tech Companies Series H
VALUATION · TODAY
$3.64B −4% after Series H+
Range $348M – $5.98B · Grade D
TODAY
+12 MO
$2.00B
$4.00B
$6.00B
$8.00B
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
Series B $15.0M
Series C $15.0M
Growth $51.0M
Series F $106M
Growth $226M
Series H+ $400M
ValuationBefore first round12-month outlook: where it points, how wide it fansHover the past: the outlook shows what was predicted then
HEADCOUNT · TODAY660 employees
+0%6m growth
+0%1y growth
−3%2y growth
1,000
2,000
Data from Jan 2021
TODAY
Predicted in 1 yr $3.49B −4% vs today
Predicted next raise $572M if a round comes
Winding-down probability 20%
Last round
Series H+ · $400M · Jul 2021
Valuation at last round
$4.00B
Headcount
660
Grade
D
Founded
2012
How VCMC values companies →

Olive valuation today

VCMC values Olive at $3.6B today, with a range of $348M to $6.0B and a grade of D. The valuation starts from its last funding round, a Series H+ round in Jul 2021.

Valuation by date (184 rows)

Each point is what the model would have shown on that date, using only what was known then; before its first round, a company is valued as a startup because it later raised.

Olive: valuation by date, as the model would have shown it on each date
DateValuationRangePredicted in 1 yrPhaseHeadcountTrendGradeWinding-down probability
1 Jan 2012$4.60M$1.67M – $12.6M$4.70M (+2%)before first round–unknownD0%
1 Feb 2012$4.60M$1.67M – $12.6M$4.72M (+3%)before first round–unknownD0%
1 Mar 2012$4.60M$1.67M – $12.6M$4.74M (+3%)before first round–unknownD0%
1 Apr 2012$4.60M$1.67M – $12.6M$4.76M (+4%)before first round–unknownD0%
1 May 2012$4.60M$1.67M – $12.6M$4.78M (+4%)before first round–unknownD0%
1 Jun 2012$4.60M$1.67M – $12.6M$4.80M (+4%)before first round–unknownD0%
1 Jul 2012$4.60M$1.67M – $12.6M$4.82M (+5%)before first round–unknownD0%
1 Aug 2012$4.61M$1.68M – $12.7M$4.84M (+5%)before first round–unknownD0%
1 Sep 2012$4.63M$1.69M – $12.7M$4.85M (+5%)before first round–unknownD0%
1 Oct 2012$4.65M$1.69M – $12.8M$4.87M (+5%)before first round–unknownD0%
1 Nov 2012$4.67M$1.70M – $12.8M$4.89M (+5%)before first round–unknownD0%
1 Dec 2012$4.69M$1.71M – $12.9M$4.91M (+5%)before first round–unknownD0%
1 Jan 2013$4.70M$1.71M – $12.9M$4.93M (+5%)before first round–unknownD0%
1 Feb 2013$4.72M$1.72M – $13.0M$4.95M (+5%)before first round–unknownD0%
1 Mar 2013$4.74M$1.73M – $13.0M$4.97M (+5%)before first round–unknownD0%
1 Apr 2013$4.76M$1.73M – $13.1M$4.99M (+5%)before first round–unknownD0%
1 May 2013$4.78M$1.74M – $13.1M$5.01M (+5%)before first round–unknownD0%
1 Jun 2013$4.80M$1.75M – $13.2M$5.03M (+5%)before first round–unknownD0%
1 Jul 2013$4.82M$1.75M – $13.2M$5.05M (+5%)before first round–unknownD0%
1 Aug 2013$4.83M$1.76M – $13.3M$5.07M (+5%)before first round–unknownD0%
1 Sep 2013$4.85M$1.77M – $13.3M$5.09M (+5%)before first round–unknownD0%
1 Oct 2013$4.87M$1.77M – $13.4M$5.11M (+5%)before first round–unknownD0%
1 Nov 2013$4.89M$1.78M – $13.4M$5.13M (+5%)before first round–unknownD0%
1 Dec 2013$4.91M$1.79M – $13.5M$5.15M (+5%)before first round–unknownD0%
1 Jan 2014$4.93M$1.79M – $13.5M$5.17M (+5%)before first round–unknownD0%
1 Feb 2014$4.95M$1.80M – $13.6M$5.19M (+5%)before first round–unknownD0%
1 Mar 2014$4.97M$1.81M – $13.6M$5.21M (+5%)before first round–unknownD0%
1 Apr 2014$4.99M$1.82M – $13.7M$5.23M (+5%)before first round–unknownD0%
1 May 2014$5.01M$1.82M – $13.8M$5.25M (+5%)before first round–unknownD0%
1 Jun 2014$5.03M$1.83M – $13.8M$5.27M (+5%)before first round–unknownD0%
1 Jul 2014$5.05M$1.84M – $13.9M$5.29M (+5%)before first round–unknownD0%
1 Aug 2014$5.07M$1.84M – $13.9M$5.31M (+5%)before first round–unknownD0%
1 Sep 2014$5.09M$1.85M – $14.0M$5.33M (+5%)before first round–unknownD0%
1 Oct 2014$5.11M$1.86M – $14.0M$5.35M (+5%)before first round–unknownD0%
1 Nov 2014$5.13M$1.87M – $14.1M$5.37M (+5%)before first round–unknownD0%
1 Dec 2014$5.15M$1.87M – $14.1M$5.39M (+5%)before first round–unknownD0%
1 Jan 2015$5.17M$1.88M – $14.2M$5.41M (+5%)before first round–unknownD0%
1 Feb 2015$5.19M$1.89M – $14.2M$5.44M (+5%)before first round–unknownD0%
1 Mar 2015$5.21M$1.90M – $14.3M$5.46M (+5%)before first round–unknownD0%
1 Apr 2015$5.23M$1.90M – $14.4M$5.48M (+5%)before first round–unknownD0%
14 Apr 2015$107M$70.4M – $245M$161M (+50%)after a round–unknownC0%
1 May 2015$109M$70.4M – $245M$161M (+47%)after a round–unknownC0%
1 Jun 2015$113M$70.4M – $245M$161M (+42%)after a round–unknownC0%
1 Jul 2015$117M$70.4M – $245M$161M (+37%)after a round–unknownC0%
1 Aug 2015$121M$70.4M – $245M$161M (+33%)after a round–unknownC0%
1 Sep 2015$125M$70.4M – $245M$161M (+28%)after a round–unknownC0%
1 Oct 2015$130M$70.4M – $245M$161M (+24%)after a round–unknownC0%
1 Nov 2015$134M$70.4M – $245M$161M (+20%)after a round–unknownC0%
1 Dec 2015$139M$70.4M – $245M$161M (+16%)after a round–unknownC0%
1 Jan 2016$143M$70.4M – $245M$161M (+12%)after a round–unknownC0%
1 Feb 2016$148M$70.4M – $245M$161M (+8%)after a round–unknownC0%
1 Mar 2016$153M$70.4M – $245M$161M (+5%)after a round–unknownC0%
1 Apr 2016$144M$102M – $266M$187M (+30%)after a round–unknownB0%
2 Apr 2016$144M$102M – $266M$187M (+30%)after a round–unknownB0%
1 May 2016$147M$102M – $266M$187M (+27%)after a round–unknownB0%
1 Jun 2016$151M$102M – $266M$187M (+24%)after a round–unknownB0%
1 Jul 2016$154M$102M – $266M$187M (+22%)after a round–unknownB0%
1 Aug 2016$157M$102M – $266M$187M (+19%)after a round–unknownB0%
1 Sep 2016$161M$102M – $266M$187M (+16%)after a round–unknownB0%
1 Oct 2016$164M$102M – $266M$187M (+14%)after a round–unknownB0%
1 Nov 2016$168M$102M – $266M$187M (+11%)after a round–unknownB0%
1 Dec 2016$172M$102M – $266M$187M (+9%)after a round–unknownB0%
1 Jan 2017$176M$102M – $266M$187M (+7%)after a round–unknownB0%
1 Feb 2017$180M$102M – $266M$187M (+4%)after a round–unknownB0%
1 Mar 2017$183M$102M – $266M$187M (+2%)after a round–unknownB0%
1 Apr 2017$187M$102M – $266M$187M (0%)after a round–unknownB0%
1 May 2017$187M$97.2M – $266M$187M (0%)after a round–unknownB0%
1 Jun 2017$187M$92.8M – $266M$187M (0%)after a round–unknownB0%
1 Jul 2017$187M$88.7M – $266M$187M (0%)after a round–unknownB0%
1 Aug 2017$187M$84.7M – $266M$187M (0%)after a round–unknownB0%
1 Sep 2017$187M$80.8M – $266M$187M (0%)after a round–unknownB0%
1 Oct 2017$187M$77.3M – $266M$187M (0%)after a round–unknownC0%
1 Nov 2017$187M$73.8M – $266M$187M (0%)after a round–unknownC0%
1 Dec 2017$187M$70.5M – $266M$187M (0%)after a round–unknownC0%
1 Jan 2018$187M$67.3M – $266M$187M (0%)after a round–unknownC0%
1 Feb 2018$187M$64.3M – $266M$187M (0%)after a round–unknownC0%
1 Mar 2018$187M$61.6M – $266M$187M (0%)after a round–unknownC0%
1 Apr 2018$187M$58.9M – $266M$187M (0%)after a round–unknownC0%
1 May 2018$187M$53.1M – $266M$187M (0%)after a round–unknownC0%
1 Jun 2018$187M$50.5M – $266M$187M (0%)after a round–unknownC0%
1 Jul 2018$187M$48.1M – $266M$187M (0%)after a round–unknownC0%
1 Aug 2018$187M$45.7M – $266M$187M (0%)after a round–unknownC0%
1 Sep 2018$187M$43.4M – $266M$187M (0%)after a round–unknownC0%
1 Oct 2018$187M$41.3M – $266M$187M (0%)after a round–unknownC0%
1 Nov 2018$187M$39.3M – $266M$187M (0%)after a round–unknownC0%
1 Dec 2018$187M$37.4M – $266M$187M (0%)after a round–unknownC0%
1 Jan 2019$187M$35.5M – $266M$187M (0%)after a round–unknownD0%
1 Feb 2019$187M$33.8M – $266M$187M (0%)after a round–unknownD0%
1 Mar 2019$187M$32.2M – $266M$187M (0%)after a round–unknownD0%
1 Apr 2019$187M$30.6M – $266M$187M (0%)after a round–unknownD0%
1 May 2019$187M$29.2M – $266M$187M (0%)after a round–unknownD0%
1 Jun 2019$187M$27.7M – $266M$187M (0%)after a round–unknownD0%
1 Jul 2019$187M$26.4M – $266M$187M (0%)after a round–unknownD0%
1 Aug 2019$187M$25.1M – $266M$187M (0%)after a round–unknownD0%
1 Sep 2019$187M$23.8M – $266M$187M (0%)after a round–unknownD0%
1 Oct 2019$187M$22.7M – $266M$187M (0%)after a round–unknownD0%
1 Nov 2019$187M$21.6M – $266M$187M (0%)after a round–unknownD0%
1 Dec 2019$187M$20.5M – $266M$187M (0%)after a round–unknownD0%
1 Jan 2020$187M$19.5M – $266M$187M (0%)after a round–unknownD0%
1 Feb 2020$187M$18.5M – $266M$187M (0%)after a round–unknownD0%
1 Mar 2020$187M$17.7M – $266M$187M (0%)after a round–unknownD0%
1 Apr 2020$567M$372M – $949M$623M (+10%)after a round–unknownB0%
1 May 2020$571M$372M – $949M$623M (+9%)after a round–unknownB0%
1 Jun 2020$576M$372M – $949M$623M (+8%)after a round–unknownB0%
1 Jul 2020$580M$372M – $949M$623M (+7%)after a round–unknownB0%
1 Aug 2020$585M$372M – $949M$623M (+7%)after a round–unknownB0%
1 Sep 2020$590M$372M – $949M$623M (+6%)after a round–unknownB0%
19 Sep 2020$1.1B$752M – $2.0B$1.4B (+30%)after a round–unknownB0%
1 Oct 2020$1.1B$752M – $2.0B$1.4B (+29%)after a round–unknownB0%
1 Nov 2020$1.1B$752M – $2.0B$1.4B (+26%)after a round–unknownB0%
1 Dec 2020$1.5B$1.3B – $1.9B$1.6B (+10%)after a round–unknownA0%
2 Dec 2020$1.5B$1.3B – $1.9B$1.6B (+10%)after a round–unknownA0%
1 Jan 2021$1.5B$1.3B – $1.9B$1.6B (+9%)after a round360unknownA0%
1 Feb 2021$1.5B$1.3B – $1.9B$1.6B (+8%)after a round360unknownA0%
1 Mar 2021$1.5B$1.3B – $1.9B$1.6B (+7%)after a round360unknownA0%
1 Apr 2021$1.5B$1.3B – $1.9B$1.6B (+7%)after a round360unknownA0%
1 May 2021$1.6B$1.3B – $1.9B$1.6B (+6%)after a round360unknownA0%
1 Jun 2021$1.6B$1.3B – $1.9B$1.6B (+5%)after a round360unknownA0%
1 Jul 2021$4.0B$3.5B – $6.0B$5.2B (+30%)after a round360unknownA0%
2 Jul 2021$4.0B$3.5B – $6.0B$5.2B (+30%)after a round360unknownA0%
1 Aug 2021$4.1B$3.5B – $6.0B$5.2B (+27%)after a round360unknownA0%
1 Sep 2021$4.2B$3.5B – $6.0B$5.2B (+24%)after a round360unknownA0%
1 Oct 2021$4.3B$3.5B – $6.0B$5.2B (+22%)after a round360unknownA0%
1 Nov 2021$4.4B$3.5B – $6.0B$5.2B (+19%)after a round360unknownA0%
1 Dec 2021$4.5B$3.5B – $6.0B$5.2B (+16%)after a round360unknownA0%
1 Jan 2022$4.6B$3.5B – $6.0B$5.2B (+14%)after a round360unknownA0%
1 Feb 2022$4.7B$3.5B – $6.0B$5.2B (+11%)after a round360unknownA0%
1 Mar 2022$4.8B$3.5B – $6.0B$5.2B (+9%)after a round360unknownA0%
1 Apr 2022$4.9B$3.5B – $6.0B$5.2B (+7%)after a round360unknownA0%
1 May 2022$5.0B$3.5B – $6.0B$5.2B (+4%)after a round1,400growingA0%
1 Jun 2022$5.1B$3.5B – $6.0B$5.2B (+2%)after a round1,400growingA0%
1 Jul 2022$5.2B$3.5B – $6.0B$5.2B (0%)after a round1,400growingA0%
1 Aug 2022$5.2B$3.3B – $6.0B$5.2B (0%)after a round1,400unknownA0%
1 Sep 2022$5.2B$3.2B – $6.0B$5.2B (0%)after a round1,400unknownB0%
1 Oct 2022$5.2B$3.0B – $6.0B$5.2B (0%)after a round1,400unknownB0%
1 Nov 2022$5.2B$2.9B – $6.0B$5.2B (0%)after a round1,400unknownB0%
1 Dec 2022$5.2B$2.8B – $6.0B$5.2B (0%)after a round1,400unknownB0%
1 Jan 2023$5.2B$2.6B – $6.0B$5.2B (0%)after a round1,400unknownB0%
1 Feb 2023$3.1B$2.4B – $4.6B$2.0B (-37%)after a round940shrinkingB97%
1 Mar 2023$3.0B$2.3B – $4.6B$1.9B (-37%)after a round940shrinkingB97%
1 Apr 2023$2.9B$2.2B – $4.6B$1.9B (-37%)after a round940shrinkingB97%
1 May 2023$2.8B$2.1B – $4.6B$1.8B (-37%)after a round940shrinkingB97%
1 Jun 2023$2.7B$2.0B – $4.6B$1.7B (-37%)after a round940shrinkingB97%
1 Jul 2023$2.6B$1.9B – $4.6B$1.7B (-37%)after a round940shrinkingB97%
1 Aug 2023$2.5B$1.8B – $4.3B$1.5B (-40%)after a round940shrinkingB97%
1 Sep 2023$2.4B$1.7B – $4.3B$1.4B (-40%)after a round940shrinkingB97%
1 Oct 2023$2.3B$1.6B – $4.2B$1.4B (-41%)after a round940shrinkingB97%
1 Nov 2023$2.9B$1.6B – $5.5B$1.9B (-33%)after a round840downC89%
1 Dec 2023$3.0B$1.5B – $5.6B$2.0B (-31%)after a round840downC82%
1 Jan 2024$3.0B$1.4B – $5.7B$2.1B (-30%)after a round840downC76%
1 Feb 2024$3.1B$1.3B – $5.8B$2.2B (-29%)after a round840downC70%
1 Mar 2024$3.2B$1.3B – $5.8B$2.3B (-28%)after a round840downC64%
1 Apr 2024$1.9B$1.2B – $4.1B$1.1B (-42%)after a round680shrinkingC97%
1 May 2024$1.8B$1.2B – $4.1B$1.0B (-42%)after a round680shrinkingC97%
1 Jun 2024$1.7B$1.1B – $4.1B$989M (-43%)after a round680shrinkingC97%
1 Jul 2024$1.6B$1.0B – $3.3B$908M (-42%)after a round680shrinkingB97%
1 Aug 2024$2.0B$995M – $6.0B$1.2B (-37%)after a round680downC97%
1 Sep 2024$1.9B$946M – $6.0B$1.2B (-37%)after a round680downC97%
1 Oct 2024$1.8B$900M – $6.0B$1.2B (-37%)after a round680downC97%
1 Nov 2024$1.8B$855M – $6.0B$1.1B (-38%)after a round680downC97%
1 Dec 2024$1.7B$814M – $6.0B$1.1B (-38%)after a round660downC97%
1 Jan 2025$1.7B$774M – $6.0B$1.0B (-38%)after a round660downD97%
1 Feb 2025$1.6B$735M – $6.0B$1.0B (-38%)after a round660downD97%
1 Mar 2025$1.6B$702M – $6.0B$975M (-38%)after a round660downD97%
1 Apr 2025$1.5B$667M – $6.0B$941M (-38%)after a round660downD97%
1 May 2025$1.6B$635M – $5.9B$1.0B (-36%)after a round660flatD89%
1 Jun 2025$1.7B$604M – $5.9B$1.2B (-33%)after a round660flatD82%
1 Jul 2025$1.7B$575M – $5.8B$1.3B (-25%)after a round660flatD76%
1 Aug 2025$1.8B$546M – $5.8B$1.4B (-22%)after a round660flatD70%
1 Sep 2025$1.9B$519M – $5.7B$1.5B (-19%)after a round660flatD64%
1 Oct 2025$2.0B$494M – $5.7B$1.7B (-17%)after a round660flatD59%
1 Nov 2025$2.1B$470M – $5.6B$1.8B (-15%)after a round660flatD54%
1 Dec 2025$2.2B$447M – $5.6B$1.9B (-13%)after a round660flatD50%
1 Jan 2026$2.2B$425M – $5.5B$2.0B (-11%)after a round660flatD46%
1 Feb 2026$2.3B$404M – $5.5B$2.1B (-10%)after a round660flatD42%
1 Mar 2026$2.7B$386M – $6.0B$2.6B (-3%)after a round660unknownD39%
1 Apr 2026$2.8B$366M – $6.0B$2.7B (-1%)after a round660unknownD36%
1 May 2026$2.9B$349M – $6.0B$2.9B (0%)after a round660unknownD33%
1 Jun 2026$3.0B$348M – $6.0B$3.0B (0%)after a round660unknownD30%
1 Jul 2026$3.2B$348M – $6.0B$3.2B (0%)after a round660unknownD28%
1 Aug 2026$3.3B$348M – $6.0B$3.1B (-5%)after a round660unknownD26%
1 Sep 2026$3.4B$348M – $6.0B$3.2B (-5%)after a round660unknownD24%
1 Oct 2026$3.5B$348M – $6.0B$3.4B (-4%)after a round660unknownD22%
24 Oct 2026$3.6B$348M – $6.0B$3.5B (-4%)after a round660unknownD20%

Key facts about Olive

Founded
2012
Headquarters
United States
Employees
about 660 -21% in a year
Total raised
$813M
Funding rounds
6
Last round
Series H Jul 2021

Olive was founded in 2012 by Bradley Mascho and Sean Lane.

Olive funding history

Olive has 6 funding rounds on record, from Apr 2015 to Jul 2021, $813M in total. The latest disclosed valuation is $4.00B post-money (Series H, Jul 2021).

  1. Series H 1 Jul 2021

    Led by Vista Equity Partners, Base10 Partners; with Tiger Global.

    Sources: thomaswdinsmore.substack.com, prnewswire.com, mobihealthnews.com and 4 more

    $400M

    $4.00B post-money

  2. Growth Equity 1 Dec 2020

    Led by Tiger Global; with General Catalyst, Drive Capital, Silicon Valley Bank, GV, Sequoia Capital, Dragoneer Investment Group, Digital Transformation Capital Partners.

    Sources: thomaswdinsmore.substack.com, prnewswire.com, mobihealthnews.com

    $226M

    $1.50B post-money

  3. Series F 18 Sep 2020

    Led by General Catalyst, Drive Capital; with Ascension, Oak HC/FT, SVB Capital.

    Sources: thomaswdinsmore.substack.com

    $106M

  4. Growth Equity 31 Mar 2020

    Led by General Catalyst; with Drive Capital, Oak HC/FT, Ascension.

    Sources: coverager.com, techcrunch.com, globenewswire.com and 3 more

    $51M

  5. Series C 1 Apr 2016

    With NCT Ventures.

    $15M

  6. Series B 13 Apr 2015

    With Drive Capital, Khosla Ventures, ACME Capital, Adverb Ventures, B Capital, Bolt, NFX, Rivet Ventures, Sequoia Capital, Thrive Capital, Y Combinator.

    Sources: thomaswdinsmore.substack.com

    $15M

Olive investors

23 investors have backed Olive; Drive Capital, General Catalyst and Tiger Global and 2 more led at least one round.

What Olive does

Olive works in tech companies, with 9 recorded offerings and customers in healthcare.

Olive is a healthcare-focused company engaged in automation and intelligence solutions for the revenue cycle, utilizing AI and machine learning technologies to enhance financial health and improve patient care experiences for healthcare organizations. The company provides autonomous revenue cycle reporting dashboards and intelligent insights to optimize revenue cycle performance and reduce patient leakage.

Description from Veridion's company data.

Products and services

  • Healthcare Revenue Cycle Automation Solutions
  • Revenue Cycle Intelligence Platform Development
  • AI-Driven Revenue Cycle Reporting Dashboard Development
  • Revenue Cycle Performance Optimization Services
  • Patient Leakage Reduction Solutions
  • Revenue Capture Enhancement Solutions
  • Healthcare Data Analytics Services
  • Healthcare Technology Integration Services
  • Patient Care Experience Improvement Solutions

Markets

  • Healthcare

Technology

  • AI and Machine Learning for Revenue Cycle Management
  • Autonomous Revenue Cycle Reporting Dashboards
  • Machine Learning for Patient Leakage Reduction

Business model

  • Business-to-Business
  • Software-as-a-Service

Industry codes (NAICS)

  • 541512 Computer Systems Design Services 100% match

Questions about Olive

What is Olive worth?

Valuation $3.6B (range $348M to $6.0B), as of 24 Oct 2026. The last disclosed valuation was $4.00B (Series H, Jul 2021).

Has Olive raised money?

Olive has 6 funding rounds on record, from Apr 2015 to Jul 2021, $813M in total. The latest disclosed valuation is $4.00B post-money (Series H, Jul 2021).

Who has invested in Olive?

Drive Capital, General Catalyst, Tiger Global, Base10 Partners, Vista Equity Partners and Ascension, and 17 more. Lead investors include Drive Capital, General Catalyst, Tiger Global and Base10 Partners.

How many people work at Olive?

About 660, down 21% over the last year. Headcount rose from 360 in Jan 2021 to 1,400 in Apr 2022, then fell to 660 in Nov 2024.

What does Olive do?

Olive works in tech companies, with 9 recorded offerings and customers in healthcare. Its main offerings are healthcare revenue cycle automation solutions, revenue cycle intelligence platform development and AI-Driven revenue cycle reporting dashboard development.

When was Olive founded, and where is it based?

Olive was founded in 2012 and is based in United States. It has about 660 employees, down 21% over the last year.